Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation and countermeasures of hypoviremia after first-line antiviral therapy in chronic HBV patients with normal ALT
ChiCTR2400092876Phase 4Recruiting
- Sponsor
- Linyi People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Linyi People's Hospital. Primary endpoints: Alanine aminotransferase (ALT), HBV DNA level and 1 more. Started Nov 2024; status: recruiting.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400092876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092876.